| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.2B | $40.3B | $41.1B | $50.5B | $46.2B | $7.9B | $8.2B | $8.9B |
| Cost of Revenue | $27.6B | $35.7B | $35.8B | $43.8B | $37.4B | $24.4B | $29.3B | $32.5B |
| Gross Profit | — | — | — | — | — | $1.2B | $1.1B | $1.1B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.6B | $1.7B | $1.6B | $1.3B | $1.3B | $1.1B | $1.2B | $1.1B |
| Operating Income | $-0.4B | $1.8B | $3.1B | $5.1B | $6.8B | $0.9B | $0.8B | $0.8B |
| Net Income | $-0.7B | $1.4B | $2.1B | $3.9B | $5.6B | $0.9B | $3.4B | $4.7B |
| EPS (Basic) | $-2.34 | $4.16 | $6.48 | $11.84 | $16.77 | $2.55 | $1.83 | $12.04 |
| EPS (Diluted) | $-2.34 | $4.15 | $6.46 | $11.81 | $16.75 | $2.55 | $1.83 | $12.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.0B | $35.7B | $37.0B | $36.4B | $36.7B | $35.4B | $30.4B | $28.3B |
| Current Assets | $10.9B | $12.3B | $13.2B | $11.8B | $12.2B | $11.6B | $9.5B | $10.6B |
| Cash & Equivalents | $3.4B | $3.4B | $3.4B | $2.2B | $1.5B | $1.8B | $0.9B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.1B | $6.7B | $7.2B | $6.8B | $7.2B | $5.5B | $5.2B | $5.5B |
| Stockholders' Equity | $10.1B | $12.5B | $12.9B | $12.6B | $11.9B | $8.0B | $8.0B | $10.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B | $3.8B | $4.9B | $6.1B | $7.7B | $3.4B | $5.0B | $5.5B |
| Investing Cash Flow | $-1.8B | $-1.9B | $-1.8B | $-2.0B | $-1.5B | $-4.9B | $-1.6B | $-3.6B |
| Capital Expenditures | $1.9B | $1.8B | $1.5B | $1.9B | $2.0B | $1.9B | $2.7B | $2.1B |
| Financing Cash Flow | $-0.5B | $-1.9B | $-1.9B | $-3.4B | $-6.4B | $2.3B | $-2.8B | $-3.0B |